Delivery Order SPE2DB22D1202-SPE2DB24FUFU1

Award Date 10/31/23
Potential Completion Date 11/1/23
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp has received a $3,017.88 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562776248 OMNIPAQUE 350 MG/ML PLUSPAK 500ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 13, 2023. No set-aside designation was applied to this award made against an indefinite-delivery contract to provide pharmaceuticals and medical supplies for DLA and...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at one thousand six hundred ninety dollars and sixty-four cents ($1,690.64) from the Defense Logistics Agency (DLA) Troop Support Medical. The order is to supply one hundred milliliters of Omnipaque 350 mg/ml infusion bottles by November 6, 2023 at Amerisourcebergen's Conshohocken, Pennsylvania headquarters. No set aside designation was applied to this award issued against an indefinite delivery contract held by...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at one thousand six hundred forty-seven dollars and thirty-six cents ($1,647.36) from the Defense Logistics Agency (DLA) Troop Support Medical. The order was awarded on November 15, 2023 to supply Omnipaque 300 mg/ml Pluspak 30ml, with performance at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, to be completed by November 16, 2023. No set-aside designation was applied to this award made against...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $1,257.45 to supply 4562872540 OMNIPAQUE 350 MG/ML PLUSPAK 500ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 22, 2023. No set aside designation was applied to this award made against an existing indefinite delivery contract to provide pharmaceuticals and critical care...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at one thousand four hundred eighty-nine dollars and sixty cents ($1,489.60) to supply one hundred milliliters (100mL) of Omnipaque 350 mg/mL injectable contrast media bottles to the Defense Logistics Agency Troop Support Medical (DLA) located in Conshohocken, Pennsylvania. Performance will take place at the prime contractor's corporate office division in...
This is a $6,378.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through June 17, 2024. This order is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at three hundred twenty-eight dollars and four cents ($328.04) to supply one hundred milliliters (100mL) of Omnipaque 300 mg/mL injectable contrast media to the Defense Logistics Agency Troop Support Medical (DLA). Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania between September 28 and 29, 2023. No subcontractors or set...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at one hundred dollars and fifty-two cents ($100.52) by the Defense Logistics Agency of the Department of Defense. The firm fixed price order is for the delivery of one hundred milliliters (100mL) of Omnipaque 350, an iodinated contrast medium used in radiology procedures, to a location in Conshohocken, Pennsylvania. Performance will take place on August 7-8, 2023 under...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,141.62, is a delivery order for the medical product "OMNIPAQUE 300 MG/ML PLUSPAK 500ML". The contract has an ultimate completion date of March 11, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a specialty pharmaceutical product. The $2,798.56 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUFU1
    Delivery Order

Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $2,514.90 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562653372 OMNIPAQUE 350 MG/ML PLUSPAK 500ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 1, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp to provide medical supplies and prescription medications to the DLA, with a value of up to $750,000 through May 2024. No set-aside designation was used for this order to support DLA's provision of pharmaceuticals and medical supplies to military treatment facilities.

Generated 1/30/24, 12:07 PM